Symposium:
225. Using Whole Genome Sequencing to Advance Infection Prevention
Saturday, October 7, 2017: 10:30 AM-12:00 PM
Room: 05AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • review the opportunities and challenges in current whole genome sequencing techniques
  • identify the role of whole genome sequencin in the evaluation of outbreaks
  • determine the opportunities afforded by whole genome sequencing in assessing endemic infections in healthcare settings

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Microbiologists, Pharmacists, Public health practitioners, Researchers

Tracks: Investigative ID, Pediatric ID, Adult ID


Chairs:  Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, FSHEA, Perelman School of Medicine, University of Pennsylvania and Tara Palmore, MD, National Institutes of Health Clinical Center

Moderators:  Mary K. Hayden, MD, FIDSA, FSHEA, Rush University Medical Center and Amy Mathers, MD, University of Virginia Health System

Presentations:
11:45 AM
Q&A

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-312-L01-P

Disclosures:

E. Lautenbach, Merck: Scientific Advisor , Consulting fee
Nabriva: Scientific Advisor , Consulting fee

T. Palmore, None

M. K. Hayden, Sage, Inc: Sage is contributing product to healthcare facilities participating in a regional collaborative on which I am a co-investigator. Neither I nor my hospital receive product. , Sage is contributing product to healthcare facilities participating in a regional collaborative on which I am a co-investigator. Neither I nor my hospital receive product.
Clorox, Inc.: Grant Investigator and I have received funding from Clorox for an investigator-initiated clinical trial. , Conducting studies in healthcare facilities that are receiving contributed product and Research support
CDC: Grant Investigator , Research grant
Molnlycke: receipt of contributed product , Conducting studies in healthcare facilities that are receiving contributed product
OpGen, Inc.: receipt of in kind laboratory services , Research support

A. Mathers, Medicines Co: Research Contractor and Scientific Advisor , Consulting fee and Research grant
Accelerate Diagnostics: Consultant and Scientific Advisor , Consulting fee
Zavante Therapeutics: Investigator , Research support

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.